Hotaling Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.49M Sell
7,353
-3
-0% -$586 0.67% 51
2022
Q3
$1.29M Sell
7,356
-46
-0.6% -$9.42K 0.62% 54
2022
Q2
$1.49M Buy
7,402
+282
+4% +$60.1K 0.65% 53
2022
Q1
$1.61M Buy
7,120
+106
+2% +$24.9K 0.62% 52
2021
Q4
$1.89M Buy
7,014
+39
+0.6% +$9.65K 0.66% 54
2021
Q3
$1.69M Sell
6,975
-4
-0.1% -$1.01K 0.7% 51
2021
Q2
$1.65M Buy
6,979
+1,393
+25% +$317K 0.67% 54
2021
Q1
$1.22M Buy
5,586
+67
+1% +$13.4K 0.55% 60
2020
Q4
$965K Buy
+5,519
New +$953K 0.45% 65

Other funds holding LH

Hotaling Investment Management's LH Position: Q4 2022 in Review

Hotaling Investment Management reduced its Labcorp (LH) stake by 0.04% in Q4 2022, selling an estimated $586 and leaving 7,353 shares worth $1.49M. The position accounts for 0.67% of the portfolio, ranked #51.

Hotaling Investment Management first reported a position in LH in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.89M in Q4 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Hotaling Investment Management held 7,353 shares of Labcorp worth $1.49M as of Q4 2022.
  • Hotaling Investment Management sold 3 Labcorp shares in Q4 2022, an estimated $586.
  • Labcorp made up 0.67% of Hotaling Investment Management's portfolio in Q4 2022, its #51 holding.
  • Hotaling Investment Management first reported a position in Labcorp in Q4 2020 and has held it in 9 quarters since.
  • Hotaling Investment Management's Labcorp position peaked at $1.89M in Q4 2021.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.